麻豆传媒

Dr. Nasir received his MD from Pakistan, followed by an MPH at John Hopkins University. Dr. Nasir completed his internal medicine residency at Boston Medical Center and a cardiology fellowship at Yale University. He also received postdoctoral research training at the division of cardiology at Johns Hopkins Hospital and was the recipient of NIH T-32 fellowship in cardiac imaging at Massachusetts General Hospital. He recently earned a Master鈥檚 degree in Health Economics and Policy Management from the London School of Economics & Political Science.

Dr. Nasir serves as Associate Editor for Circulation: Quality of Care and Outcomes, an editorial board member for Circulation as well on the board of directors for the American Society of Preventive Cardiology (ASPC). He was honored with the Johns Hopkins Distinguished Alumnus Award in 2013, which acknowledges alumni who have typified Johns Hopkins tradition of excellence and brought credit to the University by their personal accomplishments, professional achievements, or humanitarian service

Dr. Nasir has over 500 peer-reviewed articles that are published in top journals such as Lancet, New England Journal of Medicine, JAMA, Archives of Internal Medicine, Circulation, Journal of American College of Cardiology, and European Heart Journal. Dr. Nasir has lectured extensively throughout the world on coronary atherosclerosis, cardiac imaging, and prevention.

Dr. Nasir鈥檚 area of expertise in preventive cardiology involves the identification of high-risk individuals 鈥� those likely to have a heart attack or stroke. His research helps to identify the at-risk population so that treatments may be targeted to them.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program.

Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School鈥檚 Beth Israel Hospital, Dr. Post received her master鈥檚 degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital.  Dr. Post joined the Johns Hopkins faculty in 1997.

Dr. Post鈥檚 research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease,  sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA) and for the Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-study. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years.

Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation.  She has over 350 peer-reviewed research publications.  Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty.  She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow.

David A. Kass, M.D. is the Abraham and Virginia Weiss Professor of Cardiology, and Professor in the Departments of Medicine, Biomedical Engineering, Pharmacology and Molecular Sciences, and in the graduate programs of Cellular and Molecular Medicine and Pathobiology.  He received his B.A. in Applied Physics & Engineering from Harvard University in 1975 and M.D. from Yale University School of Medicine in 1980. He completed residency in Internal Medicine at George Washington University in 1983, and Cardiovascular Fellowship at Johns Hopkins University in 1986. Among his many honors are the 2020 Louis and Artur Lucien Prize in Cardiovascular Disease, the Pater Harris Distinguished Scientist Award and Innovator Award from ISHR in 2018 and 2020, Outstanding Investigator Award from the NIH, 2008 Basic Science Achievement Award from the American Heart Association, and Distinction in Teaching and Mentorship, and Clinical Innovator and Mentor Awards from Johns Hopkins University. He has trained over 100 postdoctoral fellows and graduate students, most now in academic research and leadership positions at institutions throughout the world.  Dr. Kass directs the Johns Hopkins Institute of CardioScience (ICS), and is co-director of an NIH T32 post-doctoral fellowship program in cardiovascular research that is approaching a half century of support.

Dr. Kass' research aims to expand our understanding of cardiac disease in its many manifestations, to identify novel mechanisms and avenues for treatment, and ultimately translate them to therapies in the clinic. Under his Directorship, the ICS broadly works to understand causes of cardiovascular disease using molecular and cellular biology, organ and whole animal models, regenerative medicine approaches, and bio-engineering to develop new methods for diagnosis and treatment.  In his lab, Dr. Kass and colleagues have discovered a number of new methods to treat heart failure with depressed heart function, including a form of nitric oxide called nitroxyl, an inhibitor of phosphodiesterase type 1 and type 9, a mutant form of a protein involved with protein quality control called Chip, and using a novel pacemaker strategy termed PITA. He pioneered research into how a major enzyme known as Protein Kinase G functions in the heart muscle, and how its activation can benefit heart disease. This has resulted in new discoveries with applications to heart failure, obesity, muscular dystrophy, cardiac hypertrophy and fibrosis, and even immune-cancer therapy. In addition, his laboratory is dissecting the cellular and molecular mechanisms underlying right heart disease associated with heart failure with preserved ejection fraction (HFpEF), pulmonary hypertension from systemic sclerosis, and cardiometabolic disease. His lab is funded by the National Institutes of Health, American Heart Association, and industry pursuing early-stage research therapy development.

Ongoing investigations are addressing the mechanisms and impact of stimulating cyclic GMP synthesis and/or blocking its catabolism by selective phosphodiesterases on heart disease, obesity, and cardiometabolic syndrome. Besides the well know phosphodiesterase type 5 inhibited by drugs such as Viagra庐, the Kass lab uncovered a cardiac role for phosphodiesterase type 9 that has since led to multiple clinical trials of PDE9 inhibitors in patients with heart failure. They uncovered how the cGMP-protein kinase G pathway intersects with a master growth and metabolism regulator, mTORC1, and this has implications for improving immunotherapy for the heart and cancer, work now ongoing. They also found how the protein Chip can be stabilized to help reduce abnormal protein accumulation and toxicity after a heart attack. This work is also being actively translated into a potential gene therapy for heart disease.  Clinical research is dissecting basic mechanisms for heart failure with preserved ejection fraction, pulmonary hypertension, and testing new drugs such as PDE1 inhibitors for heart failure therapies. 

Dr. Peter Kowey is one of the nation's preeminent experts in treating arrhythmia. He is a professor of medicine and clinical pharmacology at Sidney Kimmel Medical College at Thomas Jefferson University, the William Wikoff Smith Chair in Cardiovascular Research for Main Line Health and a professor for the Lankenau Institute for Medical Research (part of Main Line Health). He was System Chief, Cardiovascular Diseases, Main Line Health from 1999-2016. 

Dr. Herman K. Kado is a cardiologist in Farmington, Michigan and is affiliated with multiple hospitals in the area, including  and . He received his medical degree from Wayne State University School of Medicine and has been in practice between 11-20 years.

Specialties
SPECIALTY
Cardiology
Cardiologists diagnose and treat heart diseases, such as congenital heart defects, coronary artery disease, heart rhythm disorders and heart failure.


SUBSPECIALTIES


Interventional Cardiology
Peripheral Endovascular Interventional Cardiology
Vascular Medicine
 
Education & Experience

Medical School & Residency

Wayne State University School of Medicine
Medical School


University of Florida College of Medicine Jacksonville
Fellowship, Cardiovascular Disease, 2009-2012


Michigan State University
Fellowship, Interventional Cardiology, 2012-2013


University of Illinois College of Medicine at Chicago
Residency, Internal Medicine, 2006-2009



Certifications & Licensure

American Board of Internal Medicine
Certified in Cardiovascular Disease


American Board of Internal Medicine
Certified in Interventional Cardiology


IL State Medical License
Active through 2009


FL State Medical License
Active through 2023


MI State Medical License
Active through 2025

, is a board-certified cardiologist and medical director of heart transplant and mechanical circulatory support. He specializes in advanced heart failure, mechanical circulatory support and cardiac transplantation.
As a professor of medicine at the UC San Diego School of Medicine, Adler conducts research on the use of stem cells to treat cardiovascular disease. He is also an investigator for many clinical trials for all stages of heart failure.
Adler's work has been featured in the world's top journals, including Nature, Journal of the American Medical Association (JAMA) and Circulation. He speaks throughout the country on topics related to heart failure and stem cell biology.

, is a board-certified cardiologist. She works with patients on prevention of cardiovascular disease, as well as management of coronary disease, hypertension, hypercholesterolemia, and other cardiovascular problems. She believes good communication with her patients is an important part of the physician-patient relationship, and strives to provide evidence-based yet individualized care to each one.
Daniels is a professor of medicine at UC San Diego School of Medicine. She lectures to physicians, medical students and the general public on topics such as screening for cardiovascular disease, cardiovascular disease prevention, women's cardiovascular health, and late cardiovascular outcomes in adults with a history of Kawasaki disease.

, is a board-certified cardiologist who focuses on general and preventive cardiology, as well as women's cardiovascular health. As a general cardiologist, she works with patients to diagnose, treat and prevent heart disease, as well as manage conditions such as hypertension, coronary artery disease, valvular heart disease and congestive heart failure.
She is the founding director of the Step Family Foundation  at Jacobs Medical Center. Taub was responsible for all aspects of creating the center, which provides a comprehensive cardiac rehabilitation program for patients with established heart disease.
Taub believes that prevention is the new frontier in cardiovascular medicine. She takes an evidence-based approach to care and tailors it to each patient, with the goal of minimizing medications and procedures. She also collaborates closely with other specialists to provide cardiac care for patients with complex, multi-system diseases such as cancer and autoimmune disease.

Dr. Tamara Horwich is a cardiologist and Health Sciences Clinical Professor of Medicine/Cardiology at the David Geffen School of Medicine at UCLA. She is Medical Director of UCLA's Cardiac Rehabilitation Program, Co-Director of the UCLA Women's Cardiovascular Health Center, and an active member of the Ahmanson-UCLA Cardiomyopathy Center.
Dr. Horwich's clinical interests include treating and preventing heart disease in women, cardiac rehabilitation, treating patients with heart failure, and performing and interpreting echocardiograms. Dr. Horwich's main research interests include studying obesity, body composition and cardiovascular disease, as well as risk factors and novel therapies for patients with heart disease, with a focus on women. She has been a grant recipient from the National Institutes of Health, the Heart Failure Society of America, as well as the Iris Cantor Women's Center at UCLA. Dr. Horwich is a Fellow of the American College of Cardiology and American Heart Association and has helped draft national guidelines on management of heart failure. Dr. Horwich received a BA in History from Brown University and an MD from the Columbia University College of Physicians and Surgeons. She then returned to her native Los Angeles to complete internal medicine residency and cardiology fellowship training at UCLA, during which time she also attained a Master’s of Science in Clinical Research from UCLA.




 

Robert-Paul Juster is a neuroscience researcher. His research mainly focuses on the study of chronic stress by considering the effects of gender, sex, sexual orientation and gender identity.
Dr. Juster's research interests include the study of allostatic load, a measure of the long-term consequences of the effects of chronic stress in people. In his studies, he takes into account variables linked to gender and sex to identify possible differences and explanations. Doctor Juster is interested in both the biological and social determinants of chronic stress. In addition to being a researcher, he is director and founder of the Center for Studies on Sex*Gender, Allostasis, and Resilience (CESAR).



 

Dr Vikash was born and brought up in India and belongs to the family of Doctors. His passion and love towards clinical aspects of Medical science push him towards the research field. He is interested in Cardiovascular outcomes research and hospital work includes playing cricket, soccer, volleyball, cooking, and singing.

Dr. Toborowsky grew up in Philadelphia and attended Washington University in St. Louis for his undergraduate degree in East Asian studies. After graduation, Dr. Toborowsky worked as a zookeeper at the St. Louis Zoo for two years and fell in love with primate social systems and behavior.
Dr. Toborowsky completed a graduate degree in ecology, evolution, and systematics at the University of Missouri-St. Louis. While earning a master’s in biological anthropology at the University of Texas at Austin, Dr. Toborowsky lived on and off in Madagascar for six years and completed graduate theses on the behavior, ecology, and olfactory communica­tion of wild lemurs.
Dr. Toborowsky took some time off after graduate school to work as a tour guide and trip leader for an active travel company, leading biking and hiking trips all over the world for four years. After graduating from veterinary school at the University of Pennsylvania, Dr. Toborowsky completed a small animal rotating internship at Friendship Hospital for Animals in Washington, D.C., and a cardiology specialty internship at BluePearl in Southfield, Mich. Dr. Toborowsky did a cardiology residency at the University of Georgia and worked as a staff cardiologist at a large non-profit hospital in New York City before joining the incredible cardiology team at University of Illinois.